Crinetics Pharmaceuticals (CRNX): Wellington reports 7.13M-share, 6.76% ownership

Rhea-AI Filing Summary

Crinetics Pharmaceuticals, Inc. has a significant shareholder group led by Wellington Management entities, which collectively report beneficial ownership of 7,131,084 shares of Common Stock, representing 6.76% of the class. These shares are held of record by clients of one or more Wellington investment advisers, with Wellington Management Group LLP positioned as the ultimate parent holding company.

The Wellington complexes report no sole voting or dispositive power, instead indicating shared voting power over 6,310,651 shares and shared dispositive power over 7,131,084 shares. The filing states that the economic interests belong to advisory clients, and no single client is known to hold more than five percent of the class.

Key Figures

Beneficially owned shares: 7,131,084 shares Percent of class owned: 6.76 % Shared voting power: 6,310,651 shares +4 more

7 metrics

Beneficially owned shares 7,131,084 shares Total Crinetics common stock reported as beneficially owned by Wellington-related entities

Percent of class owned 6.76 % Overall percentage of Crinetics common stock class reported as beneficially owned

Shared voting power 6,310,651 shares Shares of Crinetics common stock with shared voting power for most Wellington entities

Shared dispositive power 7,131,084 shares Shares of Crinetics common stock with shared dispositive power for most Wellington entities

WMC LLP shared voting power 6,306,719 shares Crinetics shares over which Wellington Management Company LLP has shared voting power

WMC LLP shared dispositive power 6,793,112 shares Crinetics shares over which Wellington Management Company LLP has shared dispositive power

Ownership threshold exceeded 5 % Filing reflects ownership of more than five percent of the class of securities

Key Terms

beneficially owned, shared voting power, shared dispositive power, parent holding company, +2 more

6 terms

beneficially owned financial

"Item 4. | Ownership (a) | Amount beneficially owned: See the responses to Item 9"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

shared voting power financial

"5 | Sole Voting Power 0.00 6 | Shared Voting Power 6,310,651.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

shared dispositive power financial

"7 | Sole Dispositive Power 0.00 8 | Shared Dispositive Power 7,131,084.00"

parent holding company financial

"The securities as to which this Schedule is filed by Wellington Management Group LLP, as parent holding company"

investment advisers financial

"One or more of the following investment advisers (the "Wellington Investment Advisers")"

percent of class financial

"Item 4. | Ownership (b) | Percent of class: 6.76 %"

Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.

FAQ

What percentage of Crinetics Pharmaceuticals (CRNX) does Wellington report owning?

Wellington-related entities report beneficial ownership of 6.76% of Crinetics Pharmaceuticals’ common stock. This percentage reflects 7,131,084 shares held for advisory clients as detailed in the Schedule 13G/A amendment.

How many CRNX shares are beneficially owned by Wellington entities?

Wellington entities report 7,131,084 shares of Crinetics Pharmaceuticals common stock as beneficially owned. These securities are held of record by clients of one or more Wellington investment advisers, not directly by Wellington itself.

What voting power does Wellington have over Crinetics (CRNX) shares?

Wellington reports 0 shares with sole voting power and 6,310,651 shares with shared voting power in Crinetics. Voting authority is shared through investment advisory relationships with multiple Wellington investment advisers.

Does any single Wellington client hold over 5% of Crinetics (CRNX)?

The filing states that no single client of the Wellington investment advisers is known to have the right to receive dividends or sale proceeds for more than 5% of Crinetics’ common stock class.

Which Wellington entities are listed as reporting persons for CRNX?

The reporting persons are Wellington Management Group LLP, Wellington Group Holdings LLP, Wellington Investment Advisors Holdings LLP, and Wellington Management Company LLP. Each is part of the holding and advisory structure overseeing client investments in Crinetics.

What is Wellington Management Company LLP’s role in the CRNX holdings?

Wellington Management Company LLP is identified as an investment adviser with shared voting power over 6,306,719 shares and shared dispositive power over 6,793,112 shares of Crinetics, acting on behalf of its advisory clients.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/13/2026 - 04:12 PM Accepted by SEC EDGAR 08/13/2026 - 04:11 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 5)

Crinetics Pharmaceuticals, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

22663K107

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 22663K107

1

Names of Reporting Persons

Wellington Management Group LLP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

MASSACHUSETTS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 6,310,651.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 7,131,084.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,131,084.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.8 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

CUSIP Number(s): 22663K107

1

Names of Reporting Persons

Wellington Group Holdings LLP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 6,310,651.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 7,131,084.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,131,084.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.8 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

CUSIP Number(s): 22663K107

1

Names of Reporting Persons

Wellington Investment Advisors Holdings LLP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 6,310,651.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 7,131,084.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,131,084.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.8 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

CUSIP Number(s): 22663K107

1

Names of Reporting Persons

Wellington Management Company LLP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 6,306,719.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 6,793,112.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,131,084.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.4 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Crinetics Pharmaceuticals, Inc.
(b)	Address of issuer's principal executive offices: 6055 Lusk Blvd, San Diego CA 92121
Item 2.
(a)	Name of person filing: Wellington Management Group LLP Wellington Group Holdings LLP Wellington Investment Advisors Holdings LLP Wellington Management Company LLP
(b)	Address or principal business office or, if none, residence: c/o Wellington Management Company LLP, 280 Congress Street, Boston MA 02210
(c)	Citizenship: Wellington Management Group LLP - Massachusetts Wellington Group Holdings LLP - Delaware Wellington Investment Advisors Holdings LLP - Delaware Wellington Management Company LLP - Delaware
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 22663K107
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See the responses to Item 9 on the attached cover pages.
(b)	Percent of class: 6.76 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: See the responses to Item 6 on the attached cover pages.
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: See the responses to Item 8 on the attached cover pages.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. The securities as to which this Schedule is filed are owned of record by clients of one or more investment advisers identified in Item 7 directly or indirectly owned by Wellington Management Group LLP. Those clients have the right to receive, or the power to direct the receipt of, dividends from, or the proceeds from the sale of, such securities. No such client is known to have such right or power with respect to more than five percent of this class of securities, except as follows: Not Applicable.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. Pursuant to the instructions in Item 7 of Schedule 13G, the following lists the identity and Item 3 classification of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Wellington Group Holdings LLP - HC Wellington Investment Advisors LLP - HC Wellington Management Global Holdings, Ltd. - HC One or more of the following investment advisers (the "Wellington Investment Advisers"): Wellington Management Company LLP - IA Wellington Management Canada LLC - IA Wellington Management Singapore Pte Ltd - IA Wellington Management Hong Kong Ltd - IA Wellington Management International Ltd - IA Wellington Management Japan Pte Ltd - IA Wellington Management Australia Pty Ltd - IA The securities as to which this Schedule is filed by Wellington Management Group LLP, as parent holding company of certain holding companies and the Wellington Investment Advisers, are owned of record by clients of the Wellington Investment Advisers. Wellington Investment Advisors Holdings LLP controls directly, or indirectly through Wellington Management Global Holdings, Ltd., the Wellington Investment Advisers. Wellington Investment Advisors Holdings LLP is owned by Wellington Group Holdings LLP. Wellington Group Holdings LLP is owned by Wellington Management Group LLP.
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Wellington Management Group LLP

Signature:	Matthew Revell
Name/Title:	Compliance Manager
Date:	08/14/2026

Wellington Group Holdings LLP

Signature:	Matthew Revell
Name/Title:	Compliance Manager
Date:	08/14/2026

Wellington Investment Advisors Holdings LLP

Signature:	Matthew Revell
Name/Title:	Compliance Manager
Date:	08/14/2026

Wellington Management Company LLP

Signature:	Matthew Revell
Name/Title:	Compliance Manager
Date:	08/14/2026